Poll Archives

Click on the headline to go directly to the abstract!
Role of the PES and Tirofiban in Patients with STEMI Undergoing Postfibrinolysis Angioplasty: The GRACIA-3 Randomized Clinical Trial. PL Sánchez, F Gimeno et al. Circ Cardiovasc Interv 2010; 3:297-307
Results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) Trial. AJ Lansky, K Goto, et al. Circ Cardiovasc Interv 2010; 3:308-316
Safety and Efficacy of the Subclavian Approach for TAVI with the CoreValve Revalving System. AS Petronio, M De Carlo, et al. Circ Cardiovasc Interv 2010; 3:359-366
1-Year Results From the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) Trial. G Parodi, D Antoniucci, et al. JACC Interv 2010; 3:796-802
A TRITON–TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis In Myocardial Infarction 38) Substudy. YB Pride, P Tung, et al.   JACC Interv 2010; 3:806-811
Outcomes of PCI in Intermediate CAD: FFR–Guided versus IVUS–Guided. C-W Nam, H-J Yoon, et al. JACC Interv 2010; 3:812-817
Effect of Coronary Collaterals on Long-Term Prognosis in Patients Undergoing Primary Angioplasty for Acute STEMI. S Desch, S de Waha et al. AJC 2010; 106:605-611
Long-Term Outcomes of IVUS-Guided Stenting in Coronary Bifurcation Lesions. S-H Kim, Y-H Kim, et a AJC 2010; 106:612-618

	New Antiplatelet Agents
	The REVA Medical Bioresorbable Stent Program
	Clopidogrel Preloading: From CURE and CREDO to PRAGUE-8 and Beyond
	Lessons from the ISAR REACT Studies: How Should We Anticoagulate Our Patients for PCI
	Lessons from Pre-clinical Trials

ALPHA OMEGA: Effect of low doses of n-3 fatty acids on cardiovascular diseases in post-MI patients Daan Kromhout, MPH PhD

HEBE III: A single dose of erythropoietin in ST-elevation myocardial infarction AA Voors, MD

INNOVATE-PCI Steen D. Kristensen, MD

ATOLL G. Montalescot, MD

ART: Arterial Revascularization Trial DP Taggart, MD

FUTURA/OASIS 8 Sanjit S. Jolly, MD

Interventional Options in Diabetic Patients Prof. Dr. Sigmund Silber

Take Home Messages for Practitioners:Coronary Artery Disease Prof. Dr. Sigmund Silber

PDF Presentations

DANPACE  Jens Cosedis Neilsen, MD

AVERROES S.Connolly, MD

RESPONSE Ron JG Peters, MD

SHIFT Trial Michel Komajda

ISAR REACT 3A S. Schulz, MD

LESSON - I Stephen Windecker, MD

REACH Registry DL Bhatt, MD

Galection - 2 AM van der Laan, MD

Proteomic Analysis of Smooth Muscle Cells Louis Full, MD

This Week's Presentation: Coronary Endothelial Dysfunction After DES: Presumed Mechanisms and Assessment Techniques. Are Next Generation DES Associated with Restored Coronary Vasomotion? Aloke Finn, MD

9/1/2010	InfraReDx Receives FDA Clearance for LipiScan™ IVUS Coronary Imaging System
8/31/2010	CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up
8/31/2010	African-Americans Have Higher Risk for Blood Clots After Receiving Drug-Coated Stent
8/30/2010	InspireMD Becomes a Supporting Organization in the Growing Stent for Life Initiative
8/30/2010	Genetic Substudy Shows Fewer Major Cardiovascular Events With Ticagrelor (BRILINTA) Regardless of Relevant Genetic Variability in ACS Patients
8/30/2010	ATOLL Study Results With Intravenous Enoxaparin in Acute Heart Attack Managed With Urgent Angioplasty
8/30/2010	Philips Introduces Newly Enhanced Cardiac Ultrasound System
8/30/2010	Medtronic Receives Health Canada Approval for The Newest Radiofrequency Ablation Tools for Atrial Fibrillation